Today: 24 January 2026
Subscribe
Browse Category

NASDAQ:MDLZ News 23 January 2026

PepsiCo stock slips even as Coca-Cola rises; traders eye Feb. 3 earnings

PepsiCo stock slips even as Coca-Cola rises; traders eye Feb. 3 earnings

New York, Jan 23, 2026, 15:24 EST — Regular session PepsiCo (PEP.O) shares slipped 0.2% to $144.05 on Friday, lagging as the broader consumer staples sector climbed, leaving the snack-and-soda giant trailing its larger competitors. The market wavered amid shaky conditions. After Intel’s forecast rattled sentiment, U.S. stocks showed little direction. A Piper Sandler strategist noted investors now have “more…
23 January 2026
······

Stock Market Today

  • ImmunityBio Stock Dips 12% After Surging 200% In A Month Amid Glioblastoma Data
    January 23, 2026, 7:13 PM EST. ImmunityBio plunged 12.13% to $6.45 on Jan. 23 after soaring over 200% in the past month, driven by fresh glioblastoma survival data and profit taking. The biotech's volume surged 238% above average, reflecting volatile investor activity. ImmunityBio's recent gains followed favorable FDA resubmission plans for its Anktiva bladder cancer therapy and Saudi FDA approval. Despite today's decline, the stock remains up 63% in five days. The broader market was steady; S&P 500 edged up 0.03%, Nasdaq rose 0.28%. Analysts, including H.C. Wainwright, have increased price targets due to strong full-year results, with net profit up 700% year-on-year. Short sellers incurred significant losses, boosting buying pressure on the cancer drugmaker.
Go toTop